FDA Guidelines for GLP-1 Medications The FDA has clear criteria for prescribing GLP-1 medications for chronic weight management: a BMI of 30 or higher, or a BMI of 27 with at least one weight-related comorbidity
Use daily, morning or night, especially on dry areas
If your Aetna plan classifies Wegovy as a specialty drug or non-preferred brand, it could result in higher copays
Please note: For Intramuscular (IM) or Intravenous (IV) use only Store away from direct sunlight 1 ~ 30C Keep out of sight and reach of children Not intended to diagnose, treat, cure or prevent any disease, for promoting wellness only This is a single use ampoule, once opened, use immediately and discard any product not used All products are for sale to trained and insured professionals only who are 18+ years of age
Gut microbiota composition was analyzed using metagenomic sequencing of stool samples